Source: Eur Respir J 2015; 46: 8-10
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Culver Bruce. Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies. Eur Respir J 2015; 46: 8-10

Member's Comments

No comment yet.

Related content which might interest you: Quantification of airflow limitation in chronic obstructive pulmonary disease Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Response of lung volumes in chronic obstructive pulmonary disease patients with improvement of airflow limitation Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Mechanisms of airflow limitation characteristic of obstructive lung disease Source: Annual Congress 2004 - Simplifying the complexities of obstructive lung disease: Exploring a new therapeutic target Year: 2004 The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation? Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction Year: 2007 Asthma versus chronic obstructive pulmonary disease Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=195 Year: 2003 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 Relationship of airway dimensions with airflow limitation or lung volumes in chronic obstructive pulmonary disease (COPD) Source: Eur Respir Rev 2006; 15: 197-199 Year: 2006 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Self-efficacy. Does it change as a result of pulmonary rehabilitation? A pilot study Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management Year: 2006 Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=1 Year: 2005 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 The relationship between radiologic findings and lung function impairment in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002